AbbVie's $550M Medical Device Deal Moving Ahead
AbbVie Inc. is moving ahead with its planned $550 million acquisition of Houston-based medical device company Soliton Inc. after the Federal Trade Commission reviewed the transaction for more than six months....To view the full article, register now.
Already a subscriber? Click here to view full article